Skip to main content
. 2006 Nov 2;25(22):5260–5269. doi: 10.1038/sj.emboj.7601413

Table 1.

Summary of inhibitors and reversal/bypass agents

Inhibitor Target Reversal/bypass agents
3sQ-SNAREs R-SNARE Secl8p, PI(4,5)P2
αSecl8p Secl8p Secl8p, Vam7p
αVam3p Vam3p None known
αVps33p Vps33p None known
αYpt7 Ypt7p Ypt7p effector peptide
250 mM KC1 Unknown Lowered salt
U73122 Phospholipase C Vam7p
ENTH domain PI(4,5)P2 Chlorpromazine (CPZ)
PX domain PI(3)P Vam7p, CPZ
Clb domain Diacylglycerol Vam7p, CPZ
MED peptide PIPx CPZ, PI(4,5)P2